Neuraly is a private biotech company that is developing therapeutics for neurodegenerative diseases, including Parkinson's and Alzheimer's diseases. Neuraly is a startup from Johns Hopkins University.
Co-Founders: Dr. Han Seok Ko and Dr. Ted Dawson
Interim CEO: Seulki Lee, Ph.D.
1 article with Neuraly
Neuraly Announces Publication in Acta Neuropathologica Communications of Preclinical Data Detailing the Neuroprotective Effect of NLY01 in Models of Alzheimer’s Disease
NLY01 selectively blocks β-amyloid-induced activation of microglia through upregulated GLP-1R Neuronal viability was preserved, resulting in improved spatial learning and memory